36 studies found for:    "VLDLR-associated cerebellar hypoplasia" [DISEASE] OR "Cerebellar Ataxia" [DISEASE] OR NCT00041600 [ID-NUMBER]
Show Display Options
Rank Status Study
1 Completed Effect of Riluzole as a Symptomatic Approach in Patients With Chronic Cerebellar Ataxia
Conditions: Hereditary Ataxia;   Multiple Sclerosis;   Cerebellar Ataxia
Interventions: Drug: Riluzole;   Other: placebo
2 Completed Gluten-Free Diet in Patients With Gluten Sensitivity and Cerebellar Ataxia
Conditions: Celiac Disease;   Cerebellar Ataxia;   Healthy
Intervention:
3 Enrolling by invitation A New Method to Treat Hereditary Cerebellar Ataxia - Umbilical Cord Mesenchymal Stem Cells Transplantation
Condition: Hereditary Cerebellar Ataxia.
Intervention: Other: stem cell transplantation
4 Active, not recruiting Exercise Training Program for Cerebellar Ataxia
Condition: Cerebellar Ataxia
Intervention: Behavioral: Home exercise program
5 Recruiting Efficacy of Riluzole in Hereditary Cerebellar Ataxia
Condition: Cerebellar Ataxia
Interventions: Drug: riluzole;   Other: Placebo comparator
6 Recruiting Treatment of Cerebellar Ataxia With Mesenchymal Stem Cells
Condition: Cerebellar Ataxia
Intervention: Biological: Allogeneic adult adipose-derived mesenchymal stem cells
7 Recruiting SPATAX: Clinical and Genetic Analysis of Cerebellar Ataxias and Spastic Paraplegias
Conditions: Cerebellar Ataxias;   Spastic Paraplegias
Intervention:
8 Recruiting Phenotypic and Genotypic Studies in Congenital and Early Onset Ataxias
Conditions: Congenital Cerebellar Ataxias;   Early-onset Cerebellar Ataxias
Intervention: Genetic: blood sample
9 Recruiting Biomarkers in Autosomal Dominant Cerebellar Ataxia
Conditions: Spinocerebellar Ataxia Type 1;   Spinocerebellar Ataxia Type 2;   Spinocerebellar Ataxia, Autosomal Recessive 3;   Episodic Ataxia, Type 7
Intervention: Other: metabolic and imaging biomarkers in SCA1,2,3 and 7 patients
10 Recruiting Human Epilepsy Genetics--Neuronal Migration Disorders Study
Conditions: Epilepsy;   Seizures;   Cognition Disorders;   Neuronal Migration Disorders
Intervention:
11 Completed High-Dose Intravenous Immunoglobulin to Treat Cerebellar Degeneration
Condition: Spinocerebellar Degenerations
Intervention: Drug: high-dose intravenous immunoglobulin (IVIG)
12 Unknown  Baclofen Treatment of Ataxia Telangiectasia
Condition: Ataxia Telangiectasia
Interventions: Drug: Baclofen;   Drug: Placebo
13 Completed Clinical and Molecular Correlations in Spinocerebellar Ataxia Type 10 (SCA10)
Condition: Hereditary Ataxia
Intervention:
14 Recruiting Dalfampridine and Gait in Spinocerebellar Ataxias
Conditions: Spinocerebellar Ataxias Type 1;   Spinocerebellar Ataxias Type 2;   Spinocerebellar Ataxias Type 3;   Spinocerebellar Ataxias Type 6
Interventions: Drug: Dalfampridine;   Drug: Placebo
15 Completed Conjugate Pneumococcal Vaccine in Ataxia Telangiectasia (AT)
Condition: Ataxia Telangiectasia (AT)
Intervention: Drug: Conjugated pneumococcal vaccine (Prevenar)
16 Completed Coenzyme Q10 in Adult-Onset Ataxia
Condition: Sporadic Ataxia
Interventions: Drug: Placebo (sugar pill);   Drug: Coenzyme Q10
17 Completed A Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)
Condition: Spinocerebellar Degeneration
Interventions: Drug: KPS-0373;   Drug: Placebo
18 Unknown  Status of Growth Hormone/ Insulin-like Growth Factor-1 (GH/IGF-1) Axis and Growth Failure in Ataxia Telangiectasia (AT)
Conditions: Ataxia Telangiectasia;   Growth Failure
Intervention: Drug: Somatropin, Clonidine, L-Arginin-Hydrochloride, Estradiol valerate
19 Active, not recruiting Natural History, Genetic Bases and Phenotype-genotype Correlations in Autosomal Dominant Spinocerebellar Degenerations
Conditions: Spinocerebellar Ataxias;   Spastic Paraplegias
Intervention:
20 Completed Safety and Tolerability of Lithium in Spinocerebellar Ataxia 2 (SCA2)
Condition: SPINOCEREBELLAR ATAXIA 2
Intervention: Drug: LITHIUM CARBONATE

Previous Page Studies Shown (1-20) Next Page (21-36) Show next page of results
Indicates status has not been verified in more than two years